NEW YORK, April 19 (GenomeWeb News) - Compugen will study biological interaction networks for Novartis by using a platform for analyzing microarray and other data it intends to develop, the Tel Aviv, Israel-based company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.